HNI Corporation Common Stock (HNI)

FairStock Score: 39/100 — MIXED

Key Financials

Strengths

• Generates $157 million in annual free cash flow (5.8% yield on market cap)
• Revenue growth of 38.3% demonstrates strong top-line momentum
• Attractive 3.6% dividend yield providing steady income returns
• Established organization with 18,500 employees providing operational scale

Concerns

• Currently unprofitable—sustained losses could lead to dilutive capital raises or balance sheet deterioration
• Weak Piotroski F-Score of 2/9 suggests deteriorating financial quality across multiple dimensions
• Altman Z-Score of 1.0 places it in the financial distress zone—elevated bankruptcy risk

AI Analysis

HNI Corporation Common Stock is a small-cap consumer cyclical company valued at $2.7 billion. Revenue stands at $2.8 billion, though the company is currently unprofitable. From a quality standpoint, HNI shows weak Piotroski F-Score of 2/9 signaling deteriorating fundamentals and distressed Altman Z-Score of 1.0 warrants caution. On valuation, the stock is trading at a premium 33.5x earnings, with trades above its Graham Number with a negative 47% margin. Growth dynamics show revenue growing at 38.3% and profit growth of -228.5%. The 3.6% dividend yield adds an income component for patient holders. Our composite FairStock Score of 39/100 reflects below-average fundamentals overall. Without profitability, this remains speculative—suitable only for those with high risk tolerance and a long time horizon.

Bull Case

HNI's 38% revenue growth trajectory could accelerate as it captures additional market share in the consumer cyclical sector. With $157 million in annual free cash flow (5.8% yield), management has ample capital for buybacks, dividends, or accretive acquisitions.

Bear Case

At 34x earnings, any growth disappointment triggers rapid multiple compression—a 20% earnings miss plus multiple contraction to 20x implies 40%+ downside. Regulatory changes, input cost inflation, or demand normalization represent underappreciated risks that could materially impact forward estimates.

Data from SEC filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer